New shot could ease birch pollen misery for millions
NCT ID NCT07155499
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 22 times
Summary
This study tests a new medicine called GNR-127 for people with seasonal allergies to birch pollen. It involves 150 adults aged 18-55 who have had birch pollen allergies for at least 2 years. The goal is to find a safe and effective dose that reduces symptoms like sneezing, runny nose, and itchy eyes, and lessens the need for other allergy medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHINITIS, ALLERGIC, SEASONAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Research Center - Institute of Immunology Federal Medical-Biological Agency
Moscow, 115522, Russia
Conditions
Explore the condition pages connected to this study.